Colfax Corp
NYSE:CFX
Intrinsic Value
Colfax Corp. operates as a diversified technology company. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of CFX.
Colfax Corp's market capitalization is 10.4B USD.
CFX stock price is 66.72 USD.
CFX.
CFX. Open DCF Valuation
CFX. Open Relative Valuation
CFX.
CFX's ROE (Return on Equity) has increased in the last 3 years from 2% to 2%.
CFX's ROIC (Return on Invested Capital) has decreased in the last 3 years from 3% to 3%.
CFX has positive Operating Income for the last twelve months.
CFX's Altman Z-Score is equal to 2.66.
CFX's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
CFX's Revenue has grown by an exceptional 26% over the past 12 months.
CFX's ROE (Return on Equity) for the past 12 months is very low and is equal to 2%.
CFX has positive Free Cash Flow for the last twelve months.
CFX has a very low three-year average ROIC (Return on Invested Capital): 3%. The company is not efficient at using invested capital to generate operating income.
CFX has positive Net Income for the last twelve months.
CFX has positive Net Debt. This means that the company has more debt (2B USD) than cash and short-term investments (719m USD).
CFX has positive Gross Profit for the last twelve months.
CFX's long-term assets (9B USD) exceed its long-term liabilties (4B USD).
CFX's short-term assets (2B USD) exceed its short-term liabilties (1B USD).
CFX has negative three-year average ROE (Return on Equity): -3%. The company is not efficient at transforming stockholders' equity into net income.
CFX's D/E (Debt to Equity) is very low and is equal to 0.45.
CFX generates enough operating income (338m USD) to cover interest payments on its debt (85m USD).
Fundamental Analysis
Colfax Corp
Balance Sheet Decomposition
Colfax Corp
| Current Assets | 2.3B |
| Cash & Short-Term Investments | 719.4m |
| Receivables | 638.7m |
| Other Current Assets | 945.2m |
| Non-Current Assets | 6.2B |
| PP&E | 705.8m |
| Intangibles | 1.7B |
| Other Non-Current Assets | 3.8B |
| Current Liabilities | 1B |
| Accounts Payable | 504.2m |
| Accrued Liabilities | 407.4m |
| Other Current Liabilities | 112.1m |
| Non-Current Liabilities | 2.9B |
| Long-Term Debt | 2.1B |
| Other Non-Current Liabilities | 795.7m |
Earnings Waterfall
Colfax Corp
|
Revenue
|
3.9B
USD
|
|
Cost of Revenue
|
-2.2B
USD
|
|
Gross Profit
|
1.6B
USD
|
|
Operating Expenses
|
-1.3B
USD
|
|
Operating Income
|
337.8m
USD
|
|
Other Expenses
|
-266.1m
USD
|
|
Net Income
|
71.7m
USD
|
Free Cash Flow Analysis
Colfax Corp
CFX Profitability Score
Profitability Due Diligence
Colfax Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Colfax Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
CFX Solvency Score
Solvency Due Diligence
Colfax Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Colfax Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CFX Price Targets Summary
Colfax Corp
Ownership
CFX Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
CFX Price
Colfax Corp
| Average Annual Return | 12.4% |
| Standard Deviation of Annual Returns | 17.33% |
| Max Drawdown | -62% |
| Market Capitalization | 10.4B USD |
| Shares Outstanding | 161 167 095 |
| Percentage of Shares Shorted | 5.57% |
Company Profile
Colfax Corp
Country
Industry
Market Cap
Dividend Yield
Description
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
You don't have any saved screeners yet
